공시 • Apr 07
The funds managed by Blackstone Inc. (NYSE:BX), TPG Global, LLC along with Abu Dhabi Investment Authority and GIC Private Limited completed the acquisition of Hologic, Inc. (NasdaqGS:HOLX).
The funds managed by Blackstone Inc. (NYSE:BX), TPG Global, LLC along with Abu Dhabi Investment Authority and GIC Private Limited entered into a definitive agreement to acquire Hologic, Inc. (NasdaqGS:HOLX) for $17.2 billion on October 21, 2025. As a consideration, Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones. The merger agreement includes a 45-day “go-shop” period. Blackstone and TPG have secured committed financing for the transaction. They have delivered to Hologic a debt financing commitment letter from Citi, Bank of America, Barclays, Royal Bank of Canada and SMBC(debt financing consisting of $9,500 million of senior secured first lien term loans, $2,000 million of senior secured second lien term loans and a $750 million senior secured first lien revolving credit facility), and equity commitment letters from funds advised by Blackstone and TPG. In case of termination Hologic, Inc will pay fee of $540 million and will receive $900 million.
Upon completion of the transaction, Hologic’s common stock will be delisted from the Nasdaq stock market. The Company will maintain its headquarters in Marlborough, Massachusetts, and will continue to operate under the Hologic name and brand. China has approved private equity firms Blackstone and TPG's acquisition of medical diagnostics firm Hologic.
The transaction is expected to close in the first half of calendar year 2026, subject to the approval of Hologic’s stockholders, the receipt of required regulatory approvals, HSR act approval and the satisfaction of certain other customary closing conditions. The Hologic Board of Directors has unanimously approved the merger agreement and recommends that Hologic stockholders vote their shares to approve the transaction and adopt the merger agreement. The transaction has also been approved be the acquirer shareholders and the board. The applicable waiting period under the HSR Act was terminated early on December 17, 2025. As on February 5, 2026, the transaction has been approved by Hologic, Inc shareholders and the merger is expected to close in March or April 2026. As of February 16, 2026, the European Commission approved the acquisition of joint control of Hologic, Inc. by Blackstone Inc. and TPG Inc. under the EU Merger Regulation. As of April 6, 2026 the transaction has received all the regulatory approvals.
Goldman Sachs & Co. LLC acted as financial advisor and fairness opinion provider for Hologic, Inc. Benjamin M. Roth, Adam O. Emmerich, Franco Castelli, Erica E. Aho, Alicia C. McCarthy, Gregory E. Pessin, Jodi J. Schwartz and Rachelle Silverberg of Wachtell, Lipton, Rosen & Katz LLP acted as legal advisors for Hologic, Inc. Citigroup Inc. acted as financial advisor for TPG Global, LLC and Blackstone Inc. Daniel Yip, Christopher Burwell, Lauren Colasacco, Peter Martelli, Christopher Burwell, Daniel Yip, Melissa J. Hutson, Yuli Wang, Timothy C. Hughes, Scott Rolnik, Michael Beinus, Vivek Ratnam, Michael Krasnovsky, Matthew Wood and Yujin (Jenny) Cha of Kirkland & Ellis LLP acted as legal advisor for TPG Global, LLC. and Blackstone Inc. Christina Bergeron, Jamie Darch, Greg Levine, Lincoln Tsang, Katherine Wang and Leslie Thornton of Ropes & Gray LLP acted as legal advisor for TPG Global, LLC and Blackstone Inc. Annie Herdman of Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor to Blackstone Inc. (NYSE:BX), TPG Global, LLC. Ayo K. Badejo, Asi Kirmayer, Chad D. Ehrenkranz, Ken Daly, Sven De Knop, Rachel D. Kleinberg and James Mendenhall of Sidley Austin LLP with offices in the US and Brussels acted as legal advisors to GIC in the transaction. Okapi Partners LLC acted as information agent and Equiniti Trust Company, LLC acted as transfer agent for Hologic.
The funds managed by Blackstone Inc. (NYSE:BX), TPG Global, LLC along with Abu Dhabi Investment Authority and GIC Private Limited completed the acquisition of Hologic, Inc. (NasdaqGS:HOLX) on April 7, 2026. In connection with the completion of this transaction, Hologic today announced the appointment of José (Joe) E. Almeida as Chief Executive Officer, effective immediately. Almeida succeeds Stephen MacMillan, who recently retired from his role as Chairman, President and CEO after more than 12 years leading the organization. Hologic’s common stock has ceased trading and will be delisted from the Nasdaq Stock Market.